Camlin Fine Sciences Receives ₹5.47 Crore Income Tax Demand Notice for AY 2023-24
Camlin Fine Sciences Limited has received an income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24 related to transfer pricing adjustments on transactions with Associated Enterprises. The company disclosed this to stock exchanges under SEBI regulations and stated it plans to file an appeal against the order. The company has clarified that there is no immediate impact on its financial or operational activities due to this development.

*this image is generated using AI for illustrative purposes only.
Camlin Fine Sciences Limited has received a significant income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24, the company disclosed to stock exchanges on April 10, 2026. The notice was issued under section 156 of the Income-Tax Act, 1961, following an Assessment Order from the Income Tax Department's Assessment Unit.
Details of the Tax Demand
The demand notice requires the company to deposit the specified amount within 30 days of service. The primary reason for this substantial demand relates to transfer pricing adjustments, specifically concerning Arm's Length Price adjustments for international and domestic transactions entered into by the company with its Associated Enterprises.
| Parameter | Details |
|---|---|
| Issuing Authority | Assessment Unit, Income Tax Department |
| Demand Amount | ₹5,46,98,560 |
| Assessment Year | 2023-24 |
| Legal Provision | Section 156 of Income-Tax Act, 1961 |
| Payment Timeline | 30 days from service date |
| Receipt Date | April 10, 2026 |
Nature of Assessment
The Assessment Order was issued under section 143(3) of the Income-Tax Act, 1961. The demand primarily stems from adjustments made to the Arm's Length Price regarding the value of transactions between Camlin Fine Sciences and its Associated Enterprises. This indicates that the tax authorities have questioned the pricing of inter-company transactions and made upward adjustments, resulting in additional tax liability.
Company's Response and Impact
Camlin Fine Sciences has stated that there is no immediate impact on the company's financial, operational, or other activities due to this order. The company has examined the assessment order and is currently in the process of filing an appeal against it. This suggests that the company disagrees with the tax authorities' assessment and intends to challenge the demand through the appellate process.
Regulatory Compliance
The company has fulfilled its disclosure obligations under Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure was made simultaneously to both BSE Limited and the National Stock Exchange of India Limited, ensuring transparency with all stakeholders regarding this material development.
The disclosure was signed by Rahul Sawale, Company Secretary and VP Legal, indicating the seriousness with which the company is treating this matter and its commitment to proper corporate governance practices.
Historical Stock Returns for Camlin Fine Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.32% | +1.99% | -24.44% | -47.39% | -34.41% | -19.76% |
How might this transfer pricing dispute affect Camlin Fine Sciences' future international expansion and subsidiary structuring strategies?
What potential impact could a prolonged appellate process have on the company's cash flow and working capital management?
Will this tax demand prompt increased regulatory scrutiny of transfer pricing practices across the broader chemical and fine sciences industry?


































